Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thanks, Jack, didnt know that. There are a few I trust on what they are saying here and you are one of them.
Apparently, it has been you that has neglected reading posts about what is "going on" about this subject. This is what I have repeatedly been saying:
ooh, ok thank you. So the 15% is accurate. Didnt know that was on record, I thought the dealings between Advent and Northwest were unknown.
since there is nothing to talk about concerning NWBO let this board continue to see tea leaves in the nothing todo with NWBO company no one here has invested in Advent. There is at least a lot going on there as with Cognate back in the day which has absolutely nothing to do with NWBO.
Speaking of off-topic Advent!
I dont think its going to happen I think Less and Linda are going for the highest Advent bidder. I am pretty sure they will not do Northwest shareholders a favor by offering Advent for a pickle and a nickle. If that were the case then why the grand DTour of founding/starting a separate CDMO. No this is one of many spin-offs of Linda, I didnt know her 150 million awarded million NWBO shares were just not good enough.
so let me get this straight. First Northwest allocates expensive retail shareholders capital (this time around its not Woodford funds) to start up Advent with rent free facility and equipment and let's not forget NWBO staff including LP on full-time pay role of Northwest as a favor from one CEO of NBWO to another CEO of Advent, without any compensation... to after that then buy back Advent what it funded for free in the first place with of course retail shareholders dollars.
Wow that is really something, I call that doubled F* over
yup pretty much sounds like it
guess who will end up paying off the settling fees with future plaintiffs again for funding Advent for free as a favor of self-dealing when Northwest will get sued...
100% agree well said
thank you Lykiri
told you so
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166121838
Best,
XXXXXX
Dear XXXXXX,
Thanks for the enquiry below.
The name of the company provided to us was ADVENT BIOSERVICES LTD which will be named on the GMP certificate once approved.
Kind Regards
Inspectorate & Process licensing (OA)
Inspection, Enforcement & Standards Division
you should be less obsessed with me unless you are a 30-year centerfold but I doubt it lol
Yummie and Cheers :)
Im sorry to hear that.
Im recommending clozapine and quetiapine double dose with your Gouda Cheese
in The Netherlands, we pay 0,000000% GC
thats right we are the true capitalist nation ;)
Ofcourse we first need to make a gain on our capital in NWBO
that's, not the point BSB is making they could be paying in bitcoin, gold, dogfood for LG's new poodles or noodles for PM. The point is that, if indeed Merck is the suiter, Merck will not want to spend a huge amount or x2 for that matter for a risky take over in the cancer treatment industry within a short/mid-term period of time.
Another sobering thought is that if Merck has/had Northwest on its radar all this time then Merck does NOT see DCVAX platform as the treatment for all solid tumors as many say it is. Otherwise, why acquire Acceleron? The DCVAX platform has all the answers right so why Acceleron?
I have always said that if LP would have focussed on NWBO and DCVAX then she would have initiated Direct, now then NWBO could have counted on many suiters. But she chooses more important projects such as Cognate, Advent, an Alzheimer biotech etc.
I personally do not see an NWBO buy-out until after L is approved.
I have made that exact same argument many times over the last weeks here. I calculated the cash they will be needing to tie them over nov and dec is 11 million. Yet there are some insiders such as senti that argue that there could be new idiotic angels willing to hand them more cash aka reason to delay.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166109709
Also recently 10 million warrants have been exercised at higher strike price.. as long as there are idiotic angels willing to keep financing the hide and seek game they are playing the end of cash argument fails. So unfortunately no such luck
The receiving of a certificatie by Advent for MHRA permission to run Sawston as a bio CDMO is as material for NWBO as the Puppy training diploma for LGs new poodle
fully agree
Since its Advent, NWBO supplier and LP private holding, receiving the certificate to run Sawston as a CDMO to produce cells, I am pretty sure that this event is not material whatsoever by any SEC rule. I fail to understand why DI supposedly has said its material for NWBO. It just comes to show he doesn't know his material from his non-material.
But the PR about Advent's Sawston will indeed be with news of where NWBO in the process is.
what an incredible similarity with the last time we broke through 200
thanks sojo
I never said $1 that was the post I responded to. I think Mr Market has already taken into account this may still take 4-8 weeks without significant drops. I dont think we will not see sub 1.25$ until TLD, Unless that TLD has not arrived end Nov. But who knows for sure just a thought
so that would mean that Linda P and Less are soliciting for a couple of years of bed and breakfast at Mc Neil Island Corrections Center?
And of course, dr LL would have her MD revoked now that she keeps treating patients with the drug, That's really BAAAAAADDDD ass
Next week 1 year anniversary datalock
Who thinks LP ordered celebration cacke ?
Im not missing anything Im being realistic. Which does not make me popular around these parts I realize that. But Im not trying to win a popularity contest.
The market does only care partially about wonderful TLD. I have seen this time and again. It cares about:
- uplisting
- approval
- the reporting of tens of millions in revenue
- rumours/ actual buy-out.
- DCVAX Direct trials continuing
Some here are already contributing the WHOLE potential of DCVAX into its MC after TLD. That is not what will happen. Its absurd to think that if after TLD the MC is 25 billion it will x4 after uplising for example or x10 after approval of L or buy out.
be realistic
yes that is the only char that matters thanks!
when KITE Pharma was acquired by Gilead in 2017 Kite's revenue was $362.7M per year. Kite back then in 2017 also employed something like 1500 staff.
If NWBOs TLD will surface this year, which I really hope for, then NWBO's revenue is still close to zero. For 2022 NWBO's revenue for compassionate use, if L is not approved .. $ 100 million is a bit too steep IMO.
A good solid market-related market cap for NWBO after out-of-this-world TLD + journal publication (which I expect) is between 5-6 billion based on 900 million shares O/s IMO. By the way, could be a spike to 8 billion after TLD
SP increase effect:
- uplisting
- SP split
- the reporting of tens of millions in revenue
- rumors/ actual buy-out. I see a BO at around 22-24 billion or around that number so with 1.5 B shares $ 16 a share max
SP decrease effect
- the exercise of the tens of millions of warrants still out there
I know It had Northwest improved its cash flow. What Im saying is that the lawyers have been distracted with all kinds of other projects the last 10 years. Now, this one happens to benefit NWBO in its cashflow others not so much or not at all or even worsend.
I cant think of any other prior to revenue, prior to approval drug biotech in the US or West Europe where the CEO has so many (private) side projects and the biotech also has property on its balance sheet. Not one.
What I have heard is that management is looking at uplisting after TLD
to have any chance to become a meme stock, NWBO stock has to be available in the major Commissions free stock trading online platform apps such as WeBull and eToro without any hinder. For that to happen NWBO needs to uplist to Nasdaq and then compete with a host of other great biotech stocks out there.
Small chance that will happen
NWBO SP past present and after TLD is completely irrelevant. The only thing that counts is the NWBO market cap. $20 x let's say at that time 900 million outstanding shares would translate into an MC of $18 billion and 30 billion fully diluted for a biotech with no revenue, loads of debt, and an after TLD unapproved drug. Unless you think the market is completely irrational and idiotic thats nuts.
Im going to refrain from this discussion cause its absolutely bonkers to even contemplate.